Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions © 2001 Nature Publishing Group http://medicine.nature.com LETTERS TO THE EDITOR Our findings not only provide a novel 1. McKay, R. Stem cells-hype and hope. Nature 1 2 406, 361–364 (2000). AKIOSAIURA, MASATAKASATA, insight into the pathogenesis of the trans- 2 2 2. Asahara, T. et al.Isolation of putative progenitor YASUNOBUHIRATA, RYOZONAGAI plant-related atherosclerosis, but also point 1 endothelial cells for angiogenesis. Science275, MASATOSHIMAKUUCHI to a new therapeutic strategy that involves 964–967 (1997). Department of Surgery, University of Tokyo, 3. Yamashita, J. et al.Flk1-positive cells derived targeting of homing, differentiation and Graduate School of Medicine, Tokyo, Japan, from embryonic stem cells serve as vascular proliferation of putative smooth-muscle progenitors. Nature408, 92–96 (2000). Department of Cardiovascular Medicine University progenitor cells derived from the recipient. 4. Carmeliet, P. One cell, two fates. Nature408, of Tokyo, Graduate School of Medicine, Tokyo, Japan 43–45 (2000). This is the first report demonstrating that A.S. and M.S. supervised this study equally as 5. Clarke, D.L. et al.Generalized potential of adult circulating progenitor cells contribute to senior authors neural stem cells. Science 288, 1660–1663 the development of proliferative diseases. Email: [email protected] (2000). Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions To the editor—Apo2L/TRAIL (Apo2 ligand atom bound by http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Nature Medicine Springer Journals

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

Download PDF
3 pages

Loading next page...
 
/lp/springer-journals/differential-hepatocyte-toxicity-of-recombinant-apo2l-trail-versions-wj9tYPQpmr

References (17)

Publisher
Springer Journals
Copyright
Copyright © 2001 by Nature Publishing Group
Subject
Biomedicine; Biomedicine, general; Cancer Research; Metabolic Diseases; Infectious Diseases; Molecular Medicine; Neurosciences
ISSN
1078-8956
eISSN
1546-170X
DOI
10.1038/86397
Publisher site
See Article on Publisher Site

Abstract

© 2001 Nature Publishing Group http://medicine.nature.com LETTERS TO THE EDITOR Our findings not only provide a novel 1. McKay, R. Stem cells-hype and hope. Nature 1 2 406, 361–364 (2000). AKIOSAIURA, MASATAKASATA, insight into the pathogenesis of the trans- 2 2 2. Asahara, T. et al.Isolation of putative progenitor YASUNOBUHIRATA, RYOZONAGAI plant-related atherosclerosis, but also point 1 endothelial cells for angiogenesis. Science275, MASATOSHIMAKUUCHI to a new therapeutic strategy that involves 964–967 (1997). Department of Surgery, University of Tokyo, 3. Yamashita, J. et al.Flk1-positive cells derived targeting of homing, differentiation and Graduate School of Medicine, Tokyo, Japan, from embryonic stem cells serve as vascular proliferation of putative smooth-muscle progenitors. Nature408, 92–96 (2000). Department of Cardiovascular Medicine University progenitor cells derived from the recipient. 4. Carmeliet, P. One cell, two fates. Nature408, of Tokyo, Graduate School of Medicine, Tokyo, Japan 43–45 (2000). This is the first report demonstrating that A.S. and M.S. supervised this study equally as 5. Clarke, D.L. et al.Generalized potential of adult circulating progenitor cells contribute to senior authors neural stem cells. Science 288, 1660–1663 the development of proliferative diseases. Email: [email protected] (2000). Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions To the editor—Apo2L/TRAIL (Apo2 ligand atom bound by

Journal

Nature Medicine – Springer Journals

Published: Apr 1, 2001

There are no references for this article.